Dr Matthew Ellis
As the Director for the Lester and Sue Smith Breast Center I coordinate an interdisciplinary team of oncologists, pathologists, epidemiologists, basic scientists and statisticians focused on improving our ability to prevent, detect and treat breast cancer. In addition, I am Associate Director for Precision Medicine at the Dan L. Duncan Cancer Center, Baylor College of Medicine. I bring to these positions considerable experience in the oversight and execution of large projects and protocols of a collaborative nature on a nationwide basis. I also have a strong background in molecular cell biology, molecular pharmacology, genomics and proteomics. I have been an active member of The Breast Cancer Intergroup of North America (TCBI) since 1998 (now NCTN) and I am Co-Chair of the translational medicine committee for the NRG cooperative group. I will continue this role in the new cooperative group funding cycle. I am also Co-leader for The Cancer Genome Atlas (TCGA) Breast Project and I have established collaborations with several Genome Centers on massive parallel sequencing of breast cancer (Nature 2010, 2012). I served as a Co-PI for the second phase Clinical Proteomic Tumor Analysis Consortium (CPTAC2) grant when I was at Washington University in St Louis. During CPTAC2 I established collaborative interactions with the Broad Institute that led to a publications on the proteogenomic analysis of breast cancer (Nature 2016). I am also a U01 funded principal investigator in CPTAC3 where I continue to translate proteogenomic findings to improve the diagnosis and treatment of breast and other cancers.